Cart
sales@molnova.com
Negamycin
CAS No. 33404-78-3
Negamycin( Negamycin )
Catalog No. M14133 CAS No. 33404-78-3
A dipeptide antibiotic that inhibits the initiation of protein synthesis; also restores dystrophin expression in skeletal and cardiac muscles of the mdx mouse.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1773 | Get Quote |
|
| 50MG | 3582 | Get Quote |
|
| 100MG | 4950 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNegamycin
-
NoteResearch use only, not for human use.
-
Brief DescriptionA dipeptide antibiotic that inhibits the initiation of protein synthesis; also restores dystrophin expression in skeletal and cardiac muscles of the mdx mouse.
-
DescriptionA dipeptide antibiotic that inhibits the initiation of protein synthesis; also restores dystrophin expression in skeletal and cardiac muscles of the mdx mouse; interferes with decoding and translocation by simultaneous interaction with rRNA and tRNA.
-
In Vitro——
-
In Vivo——
-
SynonymsNegamycin
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number33404-78-3
-
Formula Weight248.283
-
Molecular FormulaC9H20N4O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)CN(C)NC(C[C@H](N)C[C@@H](O)CN)=O
-
Chemical NameN-((3R,5R)-3,6-diamino-5-hydroxyhexanamido)-N-methylglycine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Arakawa M, et al. J Biochem. 2003 Nov;134(5):751-8.
2. Polikanov YS, et al. Mol Cell. 2014 Nov 20;56(4):541-50.
3. Cocozaki AI, et al. Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):8188-93.
molnova catalog
related products
-
Clavulanate lithium
Clavulanate lithium is an inhibitor of β-lactamase.
-
Vancomycin
An antibiotic used to treat a number of bacterial infections that acts by inhibiting proper cell wall synthesis.
-
BM212
A novel antitubercular agent that possesses strong inhibitory activity against both Mycobacterium tuberculosis (MIC=0.7-1.5 ug/ml) and some nontuberculosis mycobacteria, inhibits transport activity of MmpL3.
